Authors:
OREGAN RM
CISNEROS A
ENGLAND GM
MACGREGOR JI
MUENZNAR HD
ASSIKIS VJ
BILIMORIA MM
PIETTE M
DRAGAN YP
PITOT HC
CHATTERTON R
JORDAN VC
Citation: Rm. Oregan et al., EFFECTS OF THE ANTIESTROGENS TAMOXIFEN, TOREMIFENE, AND ICI-182,780 ON ENDOMETRIAL CANCER GROWTH, Journal of the National Cancer Institute, 90(20), 1998, pp. 1552-1558
Authors:
VITZTHUM VJ
BENTLEY GR
SPIELVOGEL H
CACERES E
HEIDELBERG K
CRONE K
CHATTERTON R
Citation: Vj. Vitzthum et al., SALIVARY PROGESTERONE LEVELS AT CONCEPTION AND DURING GESTATION IN RURAL BOLIVIAN WOMEN, The FASEB journal, 12(5), 1998, pp. 4211-4211
Citation: R. Chatterton et T. Stedman, EXPERIENCES WITH CLOZAPINE AND OLANZAPINE, Australian and New Zealand Journal of Psychiatry, 32(3), 1998, pp. 463-463
Authors:
GANN P
CHATTERTON R
VOGELSONG K
DUPUIS J
ELLMAN A
Citation: P. Gann et al., MITOGENIC GROWTH-FACTORS IN BREAST FLUID OBTAINED FROM HEALTHY WOMEN - EVALUATION OF BIOLOGICAL AND EXTRANEOUS SOURCES OF VARIABILITY, Cancer epidemiology, biomarkers & prevention, 6(6), 1997, pp. 421-428
Citation: R. Chatterton et J. Mcgrath, AN OPEN-LABEL ASSESSMENT OF THE IMPACT OF CLOZAPINE ON BIOLOGICAL, PSYCHOSOCIAL AND ECONOMIC VARIABLES, Schizophrenia research, 24(1-2), 1997, pp. 186-186
Authors:
GANN PH
CHATTERTON R
VOGELSONG K
GRAYHACK JT
LEE C
Citation: Ph. Gann et al., EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES IN HUMAN PROSTATIC FLUID - SOURCES OF VARIABILITY IN ASSAY RESULTS, The Prostate, 32(4), 1997, pp. 234-240
Citation: R. Chatterton, EOSINOPHILIA AFTER COMMENCEMENT OF CLOZAPINE TREATMENT, Australian and New Zealand Journal of Psychiatry, 31(6), 1997, pp. 874-876
Citation: R. Chatterton et al., NEUROLEPTIC MALIGNANT SYNDROME AND CLOZAPINE MONOTHERAPY - RESPONSE, Australian and New Zealand Journal of Psychiatry, 31(3), 1997, pp. 435-436
Authors:
MURILLO G
KAMATH SK
CHATTERTON R
AMIN D
ALEKEL L
Citation: G. Murillo et al., SEX-HORMONES AND BODY-COMPOSITION IN INDIAN AND PAKISTAN VERSUS CAUCASIAN PREMENOPAUSAL WOMEN, The FASEB journal, 10(3), 1996, pp. 1215-1215
Citation: R. Chatterton et al., NEUROLEPTIC MALIGNANT SYNDROME AND CLOZAPINE MONOTHERAPY, Australian and New Zealand Journal of Psychiatry, 30(5), 1996, pp. 692-693